InsidersTradesSigma
Follow the AX1 stock price and the full directors' dealings record of the company, a listed equity based in Australia. Shares are quoted on the AU market, under the supervision of ASX. Operating in the Health Care sector, AX1 has published 5 reports. Market capitalisation: €438.9m. The latest transaction was disclosed on 27 August 2026 (Purchase). Among the most active insiders: Frasers Group plc (Company No. 06035106) (Frasers) and each of the persons listed in Annexure "A". Every trade is free.
Analysts rate AX1 Buy (bullish), based on 12 analysts. Average price target: A$0.83.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
AX1 是一家在医疗保健和制药领域运营的公司，在 XASX 上市。它专注于开发创新解决方案以改善医疗保健。